Updated: Jan 13, 2021
CEO and Co-Founder, Quantum Surgical
Bertin, entrepreneur in surgical robotics, came together with his associates and conducted research that showed 8 000 new cases of liver cancer arise in France alone in each year, and 800 000 globally. The company began to explore the potential of minimally-invasive surgical robotics for the treatment of such cancer.
Quantum Surgical aimed to conceive an innovative solution that resulted in minimally invasive therapies in liver cancer from combining powerful software and a robotic platform.
Artificial Intelligence (AI), robotics, and imaging analytics would allow patients to benefit from safer interventional oncology procedures.
Ensuring hundreds and thousands of people worldwide acquire safer interventional oncology procedures, minimizing the rates of people passing from the disease.